S David Kimball Selected Research

BMS 189090

1/2002

Thrombin active site inhibitors: chemical synthesis, in vitro and in vivo pharmacological profile of a novel and selective agent BMS-189090 and analogues.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

S David Kimball Research Topics

Disease

9	Neoplasms (Cancer) 01/2019 - 08/2002
2	Venous Thrombosis (Deep-Vein Thrombosis) 01/2002 - 01/2002
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Hepatocellular Carcinoma (Hepatoma) 01/2017
1	Rheumatoid Arthritis 12/2010
1	Glaucoma 11/2009
1	Ocular Hypertension (Glaucoma, Suspect) 11/2009
1	Type 2 Diabetes Mellitus (MODY) 10/2009
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 07/2008
1	Vomiting 07/2008
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 07/2008

Drug/Important Bio-Agent (IBA)

3	ZincIBA 01/2019 - 05/2015
3	Pharmaceutical PreparationsIBA 01/2017 - 10/2014
2	MetallochaperonesIBA 01/2019 - 01/2018
2	Thrombin FDA Link 01/2002 - 01/2002
1	olaparibIBA 01/2019
1	LyasesIBA 12/2010
1	1- (4- (1,2,3,4- tetrahydroxybutyl)- 1H- imidazol- 2- yl)ethanone oximeIBA 12/2010
1	1- (2- (isoxazol- 3- yl)- 1H- imidazol- 4- yl)butane- 1,2,3,4- tetraolIBA 12/2010
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 12/2010
1	OximesIBA 12/2010
1	Therapeutic UsesIBA 12/2010
1	SteroidsIBA 11/2009
1	Lim KinasesIBA 11/2009
1	Glucose (Dextrose)FDA LinkGeneric 10/2009
1	Sodium-Glucose Transporter 2 InhibitorsIBA 10/2009
1	Xylose (D-Xylose)FDA Link 10/2009
1	SodiumIBA 10/2009
1	Serotonin (5 Hydroxytryptamine)IBA 07/2008
1	Tryptophan HydroxylaseIBA 07/2008
1	alvocidib (flavopiridol)IBA 03/2004
1	Antineoplastic Agents (Antineoplastics)IBA 03/2004
1	Cyclin EIBA 08/2002
1	BMS 189090IBA 01/2002
1	BMS 189664IBA 01/2002

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2019 - 07/2008
2	Therapeutics 01/2018 - 01/2017
1	Oral Administration 12/2010